It’s something that many of us reckon with: the sense that we’re not quite as sharp as we once were. I recently turned 42. Having lost my grandfather to Alzheimer’s, and with my mom suffering...

The addition of the antitumor medication masitinib to standard of care significantly slowed cognitive deterioration and improved overall functioning for patients with mild to moderate Alzheimer’s...

Plasma biomarkers such as amyloid-beta 40 and 42, phosphorylated tau 181 and 217, and neurofilament light hold great promise for diagnosing and determining a prognosis for Alzheimer’s disease. Such...

An expert panel has released the first recommendations on the appropriate use of aducanumab (Aduhelm), the controversial anti-amyloid drug that was approved by the US Food and Drug Administration (FDA)...

An influential, independent panel unanimously voted that aducanumab (Aduhelm) offers no benefit for patients with Alzheimer’s disease (AD), adding to growing opposition from medical experts to the...

Amid significant controversy, the US Food and Drug Administration (FDA) last week approved the antiamyloid agent aducanumab (Aduhelm) for the treatment of Alzheimer’s disease, disregarding the recommendation...

In a novel study, researchers focus on encoding of the brain and claim new ways to enhance memory for the people suffering from traumatic brain diseases like Alzheimer. The findings published in PNAS and...

(HealthDay)—Older adults who have surgery with general anesthesia may experience a modest cortical thinning in the brain, but it does not appear to be tied to Alzheimer disease, according to a study...